Analysis of polyomavirus-infected renal transplant recipients' urine specimens: Correlation of routine urine cytology, fluorescence in situ hybridization, and digital image analysis

American Journal of Clinical Pathology

Volumn 124, Issue 6, 2005, Pages 854-861

  Kipp, Benjamin R ^a   Sebo, Thomas J ^a   Griffin, Matthew D ^a   Ihrke, Johnita M ^a   Halling, Kevin C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Decoy cell; FISH; Fluorescence in situ hybridization; Image cytometry; UroVysion

Indexed keywords

VIRUS DNA;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CHROMOSOME 9P; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOLOGY; DNA CONTENT; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; HUMAN CELL; IMAGE ANALYSIS; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CELL; MALE; POLYMERASE CHAIN REACTION; POLYOMA VIRUS; PRIORITY JOURNAL; RECIPIENT; URINALYSIS; VIRUS INFECTION; VIRUS TYPING;

EID: 28444490369     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/6WMTXBFHWP7FLKH6     Document Type: Article

References (37)

1. Mayr M, Nickeleit V, Hirsch HH, et al. Polyomavirus BK nephropathy in a kidney transplant recipient: critical issues of diagnosis and management. Am J Kidney Dis. 2001;38:E13.
2. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol. 1999;10:1080-1089.
3. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis. 2003;3:611-623.
4. Hirsch HH. Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Am J Transplant. 2002;2:25-30.
5. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347:488-496.
6. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol. 2002;13:2145-2151.
7. Drachenberg CB, Beskow CO, Cangro CB, et al. Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol. 1999;30:970-977.
8. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med. 2000;342:1361-1363.
9. Purighalla R, Shapiro R, McCauley J, et al. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis. 1995;26:671-673.
10. Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation. 1999;67:918-922.
11. Buehrig CK, Lager DJ, Stegall MD, et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int. 2003;64:665-673.
12. Seftel AD, Matthews LA, Smith MC, et al. Polyomavirus mimicking high grade transitional cell carcinoma. J Urol. 1996;156:1764.
13. Halling KC, King W, Sokolova IA, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol. 2000;164:1768-1775.
14. Hailing KC. Vysis UroVysion for the detection of urothelial carcinoma. Expert Rev Mol Diagn. 2003;3:507-519.
15. Shabaik AS, Pow-Sang JM, Lockhart J, et al. Role of DNA image cytometry in the follow-up of patients with urinary tract transitional cell carcinoma. Anal Quant Cytol Histol. 1993;15:115-123.
16. de la Roza GL, Hopkovitz A, Caraway NP, et al. DNA image analysis of urinary cytology: prediction of recurrent transitional cell carcinoma. Mod Pathol. 1996;9:571-578.
17. Dalquen P, Kleiber B, Grilli B, et al. DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine. Cancer. 2002;96:374-379.
18. Mora LB, Nicosia SV, Pow-Sang JM, et al. Ancillary techniques in the followup of transitional cell carcinoma: a comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients. J Urol. 1996;156:49-54; discussion 54-55.
19. Sarosdy MF, Schellhammer P, Bokinsky G, et al. Clinical evaluation of multi-target fluorescent in situ hybridization assay for the detection of bladder cancer. J Urol. 2002;168:1950-1954.
20. Skacel M, Fahmy M, Brainard JA, et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol. 2003;169:2101-2105.
21. Sokolova IA, Halling KC, Jenkins RB, et al. The development of multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn. 2000;2:116-123.
22. van Velthoven R, Petein M, Oosterlinck WJ, et al. The use of digital image analysis of chromatin texture in Feulgen-stained nuclei to predict recurrence of low grade superficial transitional cell carcinoma of the bladder. Cancer. 1995;75:560-568.
23. Wojcik EM, Miller MC, Wright BC, et al. Comparative analysis of DNA content in polyomavirus-infected urothelial cells, urothelial dysplasia and high grade transitional cell carcinoma. Anal Quant Cytol Histol. 1997;19:430-436.
24. DeMay RM. The Art and Science of Cytopathology. Chicago, IL: ASCP Press; 1996:395.
25. Sebo TJ. Digital image analysis. Mayo Clin Proc. 1995;70:81-82.
26. Focus Technologies. Detection and Quantification of BK Virus DNA by PCR. Cypress, CA: Focus Technologies; 2004.
27. Papanicolaou GN, Marshall VF. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science. 1945;101:519-520.
28. Skacel M, Pettay JD, Tsiftsakis EK, et al. Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid-based cytology slides. Anal Quant Cytol Histol. 2001;23:381-387.
29. Veeramachaneni R, Nordberg ML, Shi R, et al. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Diagn Cytopathol. 2003;28:301-307.
30. Brown F. Urine cytology: it is still the gold standard for screening. Urol Clin North Am. 2000;27:25-37.
31. Halling KC, King W, Sokolova IA, et al. A comparison of BTA stat, hemoglobin dipstick, telomerase, and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J Urol. 2002;167:2001-2006.
32. Bubendorf L, Grilli B, Sauter G, et al. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol. 2001;116:79-86.
33. Master VA, Meng MV, Koppie TM, et al. Origin of urothelial carcinoma after renal transplant determined by fluorescence in situ hybridization. J Urol. 2002;167:2521-2522.
34. Glassman DT, Sklar GN. Complete genitourinary exenteration for multifocal transitional cell carcinoma in renal transplant recipient. J Urol. 2001;166:986-987.
35. Schmidt R, Stippel D, Krings F, et al. Malignancies of the genito-urinary system following renal transplantation. Br J Urol. 1995;75:572-577.
36. Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer. 1995;60:183-189.
37. Chieco P, Derenzini M. The Feulgen reaction 75 years on. Histochem Cell Biol. 1999;111:345-358.